{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"16.0","value":"26.5"},{"groupId":"OG001","spread":"13.0","value":"52.2"},{"groupId":"OG002","spread":"30.0","value":"79.5"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"6"}],"units":"Participants"}],"description":"Evaluate the maximum plasma concentration (Cmax) of ONM-100 at the dose(s) and imaging schedule(s) post dose used to assess optimal imaging at doses of 1 mg/kg, 2 mg/kg and 3 mg/kg.","dispersionType":"Geometric Coefficient of Variation","groups":[{"description":"All patients in the study who received a single IV administration of ONM-100 at 1 mg/kg.","id":"OG000","title":"Patients Receiving ONM-100 a Dose of 1 mg/kg"},{"description":"All patients in the study who received a single IV administration of ONM-100 at 2 mg/kg.","id":"OG001","title":"Patients Receiving ONM-100 at a Dose of 2 mg/kg"},{"description":"All patients in the study who received a single IV administration of ONM-100 at 3 mg/kg.","id":"OG002","title":"Patients Receiving ONM-100 at a Dose of 3 mg/kg"}],"paramType":"GEOMETRIC_MEAN","populationDescription":"The PK analysis population is comprised 19 patients for whom concentration data were available. Due to sparse plasma concentrations for the majority of patients, with the exception of Cmax and Tmax, it was not possible to estimate all parameters for all patients.","reportingStatus":"POSTED","timeFrame":"6 days","title":"Evaluate Pharmacokinetic Parameters: Cmax","type":"SECONDARY","unitOfMeasure":"μg/mL"}